259
Participants
Start Date
December 31, 2011
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Depo-Eligard®
Subcutaneous
Site: 23, Brussels
Site: 13, Brussels
Site: 24, Uccle
Site: 26, Lasne-Chapelle-Saint-Lambert
Site: 5, Antwerp
Site: 8, Antwerp
Site: 9, Antwerp
Site: 14, Antwerp
Site: 33, Merksem
Site: 4, Antwerp
Site: 1, Turnhout
Site: 18, Tienen
Site: 37, Sint-Truiden
Site: 38, Liège
Site: 39, La Louvière
Site: 31, Ostend
Site: 25, Kortijk
Site: 20, Izegem
Site: 21, Ieper
Site: 11, Ghent
Site: 34, Dendermonde
Site: 32, Aalst
Site: 17, Oudenaarde
Collaborators (1)
Veeda Clinical Research
INDUSTRY
Astellas Pharma Europe B.V.
INDUSTRY